Gotham Asset Management’s ANI Pharmaceuticals ANIP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-4,929
| Closed | -$314K | – | 1413 |
|
|
2024
Q2 | $314K | Sell |
4,929
-2,821
| -36% | -$180K | ﹤0.01% | 1213 |
|
|
2024
Q1 | $536K | Sell |
7,750
-1,519
| -16% | -$105K | 0.01% | 1023 |
|
|
2023
Q4 | $511K | Buy |
9,269
+4,165
| +82% | +$230K | 0.01% | 984 |
|
|
2023
Q3 | $296K | Buy |
+5,104
| New | +$296K | 0.01% | 1123 |
|
|
2018
Q4 | – | Sell |
-14,451
| Closed | -$817K | – | 974 |
|
|
2018
Q3 | $817K | Sell |
14,451
-1,511
| -9% | -$85.4K | 0.01% | 643 |
|
|
2018
Q2 | $1.07M | Buy |
+15,962
| New | +$1.07M | 0.02% | 582 |
|
|
2017
Q1 | – | Sell |
-4,137
| Closed | -$251K | – | 985 |
|
|
2016
Q4 | $251K | Sell |
4,137
-626
| -13% | -$38K | ﹤0.01% | 845 |
|
|
2016
Q3 | $316K | Sell |
4,763
-2,561
| -35% | -$170K | ﹤0.01% | 773 |
|
|
2016
Q2 | $409K | Sell |
7,324
-4,364
| -37% | -$244K | ﹤0.01% | 758 |
|
|
2016
Q1 | $393K | Buy |
+11,688
| New | +$393K | ﹤0.01% | 800 |
|
|
2015
Q4 | – | Sell |
-24,801
| Closed | -$980K | – | 864 |
|
|
2015
Q3 | $980K | Buy |
24,801
+11,743
| +90% | +$464K | 0.01% | 622 |
|
|
2015
Q2 | $810K | Sell |
13,058
-25,621
| -66% | -$1.59M | 0.01% | 668 |
|
|
2015
Q1 | $2.42M | Buy |
38,679
+34,594
| +847% | +$2.16M | 0.02% | 501 |
|
|
2014
Q4 | $230K | Buy |
+4,085
| New | +$230K | ﹤0.01% | 890 |
|